Corient Capital Partners, LLC Takeda Pharmaceutical CO LTD Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Corient Capital Partners, LLC holds 21,574 shares of TAK stock, worth $284,345. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,574
Previous 21,574
-0.0%
Holding current value
$284,345
Previous $303,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding TAK
# of Institutions
340Shares Held
76MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$173 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X012.1MShares$159 Million2.47% of portfolio
-
Morgan Stanley New York, NY5MShares$65.8 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.21MShares$55.5 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.12MShares$41.1 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...